Evidence map›Paper›PMID 24803680›Full record

ArticlePhysiological genomics2014

Transcriptional atlas of cardiogenesis maps congenital heart disease interactome.

Xing Li, Almudena Martinez-Fernandez, Katherine A Hartjes, Jean-Pierre A Kocher, Timothy M Olson, Andre Terzic, Timothy J Nelson

Open access · greenAbstract read
In one paragraph

Article in Physiological genomics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Regenerative therapy · 2026
    Article
  3. Article
  4. Article
  5. Infliximab Limits Injury in Myocardial Infarction.Journal of the American Heart Association · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Fish-Ing for Enhancers in the Heart.International journal of molecular sciences · 2021
    Review
  13. Mending a broken heart:Disease models & mechanisms · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Hypoplastic left heart syndrome: From bedside to bench and back.Journal of molecular and cellular cardiology · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xing LiDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota;
Almudena Martinez-FernandezDivision of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota;
Katherine A HartjesDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota;
Jean-Pierre A KocherDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota;
Timothy M OlsonDivision of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota; Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota;
Andre TerzicDivision of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota; Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota;
Timothy J NelsonDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota; Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota; Transplant Center, Mayo Clinic, Rochester, Minnesota; and Division of General Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota nelson.timothy@mayo.edu.
Mayo Clinic · USMayo Clinic in Florida · USWinnMed · US

Funding

Predoctoral Training Program in Molecular PharmacologyT32GM072474 · NIGMS · MAYO CLINIC ROCHESTER · PI KARNITZ, LARRY M · 2005 to 2020
$2.4M
Dysfunctional regeneration in cardiomyopathy: iPS-based diagnosis and therapyDP2OD007015 · OD · MAYO CLINIC ROCHESTER · PI NELSON, TIMOTHY JAMES · 2010 to 2010
$2.4M
NIGMS NIH HHS T32 GM072474NIH HHS OD007015-01
6 · The paper itself

Abstract

Mammalian heart development is built on highly conserved molecular mechanisms with polygenetic perturbations resulting in a spectrum of congenital heart diseases (CHD). However, knowledge of cardiogenic ontogeny that regulates proper cardiogenesis remains largely based on candidate-gene approaches. Mapping the dynamic transcriptional landscape of cardiogenesis from a genomic perspective is essential to integrate the knowledge of heart development into translational applications that accelerate disease discovery efforts toward mechanistic-based treatment strategies. Herein, we designed a time-course transcriptome analysis to investigate the genome-wide dynamic expression landscape of innate murine cardiogenesis ranging from embryonic stem cells to adult cardiac structures. This comprehensive analysis generated temporal and spatial expression profiles, revealed stage-specific gene functions, and mapped the dynamic transcriptome of cardiogenesis to curated pathways. Reconciling known genetic underpinnings of CHD, we deconstructed a disease-centric dynamic interactome encoded within this cardiogenic atlas to identify stage-specific developmental disturbances clustered on regulation of epithelial-to-mesenchymal transition (EMT), BMP signaling, NF-AT signaling, TGFb-dependent EMT, and Notch signaling. Collectively, this cardiogenic transcriptional landscape defines the time-dependent expression of cardiac ontogeny and prioritizes regulatory networks at the interface between health and disease.

Indexed as

Gene Expression Regulation, DevelopmentalGene Regulatory NetworksAnimalsEmbryo, MammalianEmbryonic Stem CellsGene Expression ProfilingHeartHeart Defects, CongenitalHigh-Throughput Screening AssaysMiceMyocardiumMyocytes, CardiacOrganogenesisProtein Interaction Mapscardiogenesiscongenital heart diseaseheart developmenttime course microarraytranscriptome

Identifiers

PMID24803680
PMCPMC4080280
OpenAlexW2118600633

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.